Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants
International Journal of Molecular Sciences · 23.04.2025 · 26 (9) · 3966
DOI: 10.3390/ijms26093966 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.04.2025. Verfasst von Abhishikt David Solomon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Adams School of Dentistry, Oral and Craniofacial Biomedicine, University of North Carolina, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocytes, Cardiac, Cardiotoxicity, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 300 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy-related cardiotoxicity (CTRTOX) is a profound and common side effect of cancer-based therapy in a subset of patients. The underlying factors and the associated mechanisms contributing to severe toxicity of the heart among these patients remain unknown. While challenges remain in accessing human subjects and their ventricular cardiomyocytes (CMs), advancements in human induced pluripotent stem cell (hiPSC)-technology-based CM differentiation protocols over the past few decades have paved the path for iPSC-based models of human cardiac diseases. Here, we offer a detailed analysis of the underlying mechanisms of CTRTOX. We also discuss the recent advances in therapeutic strategies in different animal models and clinical trials. Furthermore, we explore the prospects of iPSC-based models for identifying novel functional targets and developing safer chemotherapy regimens for cancer patients that may be beneficial for developing personalized cardioprotectants and their application in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Adams School of Dentistry, Oral and Craniofacial Biomedicine, University of North Carolina, Chapel Hill, NC 27599, USA.
- Maharishi Markandeshwar College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala 133207, India.
- Department of Biomedical Engineering and Bioinformatics, Swami Vivekanand Technical University, Durg 491107, India.
- ReNeuroGen LLC, Milwaukee, WI 53122, USA.
- Department of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
- Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
ORCID-Profile: Swarna Dabral, Billy W Day, Matea Juric, Jacek Zielonka, Tarun Pant
Zitieren
APA
Solomon, A. D., Dabral, S., Brajesh, R. G., Day, B. W., Juric, M., Zielonka, J., Bosnjak, Z. J., & Pant, T. (2025). Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants. International Journal of Molecular Sciences, 26(9), 3966. https://doi.org/10.3390/ijms26093966
Vancouver
Solomon AD, Dabral S, Brajesh RG, Day BW, Juric M, Zielonka J, et al. Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants. International Journal of Molecular Sciences. 2025;26(9):3966. doi:10.3390/ijms26093966
BibTeX
@article{Solomon2025,
author = {Solomon, Abhishikt David and Dabral, Swarna and Brajesh, Raman Gulab and Day, Billy W and Juric, Matea and Zielonka, Jacek and Bosnjak, Zeljko J and Pant, Tarun},
title = {Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {3966},
doi = {10.3390/ijms26093966}
}
EUVIMED